Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Hockey India on Monday announced the 20-member squad for the Men's Junior Asia Cup, a qual
- Harmanpreet Singh named FIH Player of the Year, PR Sreejesh gets best goalkeeper award
- World Boxing medallist Gaurav Bidhuri to flag off 'Delhi Against Drugs' movement on Nov 17
- U23 World Wrestling Championship: Chirag Chikkara wins gold as India end campaign with nine medals
- FIFA president Infantino confirms at least 9 African teams for the 2026 World Cup
- Hockey, cricket, wrestling, badminton, squash axed from 2026 CWG in Glasgow
Covid-19 vaccine to be rolled out within 3 months in UK: Report Last Updated : 04 Oct 2020 11:25:00 AM IST File Photo The Covid-19 vaccine developed by scientists at the Oxford University, which is advanced stages of the trial, could be rolled out in as little as three months in the UK, a report said.
According to the Times, a mass roll-out of a coronavirus vaccine could be completed in as little as three months, raising the prospect of every adult in the country receiving a jab as early as Easter.Scientists working on the Oxford vaccine hope it could be approved by regulators before the start of next year, with some health officials estimating that every adult could receive a dose within six months.Government sources involved in making and distributing the vaccines told The Times that they expected a full programme, which would exclude children, could take six months or less after approval, and would probably be significantly quicker.Meanwhile, European Medicines Agency (EMA) said on Thursday it has started reviewing data on AstraZeneca and Oxford University's potential Covid-19 vaccine, in real-time, the first of such moves aimed at speeding up any approval process in the region for a vaccine.According to the reports, the agency has raised the chances of the British vaccine, which is seen as leading the race for a successful vaccine against Covid-19.The vaccine has been developed by Oxford University and British-Swedish pharmaceutical firm AstraZeneca.Also, the Serum Institute of India has tied up with AstraZeneca to produce doses of the vaccine in India. The trials will be conducted on 1,600 participants across the country.IANS London For Latest Updates Please-
Join us on
Follow us on
172.31.16.186